St. George's University School of Medicine

SHERMAN OAKS, Calif., Feb. 13, 2026 /PRNewswire/ -- Austin Harris MD, a board-certified cardiothoracic anesthesiologist and Medical Director of NeuroRelief Ketamine & Infusion Therapy, is transforming the treatment landscape for mental health, chronic pain, and substance use recovery through deeply personalized, integrative medical care. With more than 12 years of advanced anesthesiology experience and extensive clinical expertise in IV ketamine and nutrient-based infusion therapies, Dr. Austin Harris specializes in treating individuals who have not found relief through conventional approaches. His programs address depression, anxiety, PTSD, migraines, chronic pain syndromes, and addiction recovery using evidence-based protocols designed around each patient's unique biology and personal goals. Dr. Austin Harris's treatment philosophy is rooted in a "one-size-fits-one" approach. Through fully integrated programs that combine IV Ketamine Infusion Therapy, NAD+ Infusions, and customized micronutrient replacement, Dr. Austin Harris and his team have achieved an 85% success rate in improving patient outcomes. Unlike traditional models of care, Dr. Austin Harris works one-on-one with every patient, providing individualized guidance and continuous support. Patients also receive seven-days-a-week direct access to Dr. Austin Harris, ensuring real-time communication and continuity of care throughout their healing journey. Founded in 2019, NeuroRelief Ketamine & Infusion Therapy reflects Dr. Austin Harris's commitment to compassionate, science-driven treatment. His professional background includes years of experience in perioperative medicine, cardiac and thoracic anesthesia, and critical care, enabling Dr. Austin Harris to deliver ketamine therapy with the highest standards of safety and clinical precision. About Dr. Austin Harris, MD Austin Harris MD is a board-certified cardiothoracic anesthesiologist with more than 16 years of experience in anesthesiology and integrative medical treatments, including IV ketamine therapy. Dr. Austin Harris earned his Doctor of Medicine degree magna cum laude from St. George's University School of Medicine, completed his anesthesiology residency at the University of California, Irvine, and pursued a fellowship in Cardiothoracic Anesthesiology at the Keck School of Medicine of USC. Dr. Austin Harris is certified in Psychedelic Integration Therapy and Psychedelic-Assisted Psychotherapy through Fluence and is widely recognized for blending advanced medical science with applied mindfulness and trauma-informed care. SOURCE Dr. Austin Harris NeuroRelief 21% more press release views with Request a Demo

Board-certified surgeon and neuroscience expert Dr. Sepehr Lalezari of Lalezari Surgical in Los Angeles was recently featured on ABC7 Eyewitness News to discuss emerging research on the brain-boosting benefits of creatine supplementation. The segment, which aired as part of the station's "7 On Your Side" series, highlighted how creatine may support cognitive function, increase energy availability in the brain, and offer neuroprotective benefits beyond its well-known role in athletic performance. LOS ANGELES, Feb. 11, 2026 /PRNewswire/ -- Dr. Sepehr Lalezari, a double board-certified surgeon and founder of Lalezari Surgical in Los Angeles, was recently featured as a medical expert on ABC7 Eyewitness News in a segment exploring whether creatine supplementation can help boost brain activity. Long associated with gym culture and athletic performance, creatine is now gaining attention in the medical and scientific communities for its potential cognitive and neuroprotective benefits. Continue Reading Dr. Sepehr Lalezari In the ABC7 segment, which aired as part of the station's popular "7 On Your Side" series on January 26, 2025, Dr. Lalezari explained how creatine works beyond the muscles to support brain function. He described how the supplement helps increase energy available to the brain and may play a role in supporting and protecting neurons. This is consistent with a growing body of research suggesting that creatine supplementation can improve cognitive performance, particularly during periods of heightened metabolic stress such as sleep deprivation, aging, and the postpartum period. The segment noted that while creatine is generally considered safe for most adults, individuals with kidney conditions should consult their physician before beginning supplementation. Dr. Lalezari emphasized that it is always advisable to speak with a healthcare provider before starting any new supplement regimen. The broadcast also highlighted the accessibility of creatine, noting that it is affordable and widely available at nutrition stores and online. "When most people think of creatine, they think of the gym and building muscle, but the science is showing us that it does much more than that," says Dr. Lalezari. "Creatine helps increase energy in the brain and may also support and protect neurons. As someone who studied neuroscience at UCLA before pursuing surgery, I find the emerging research on creatine and brain health incredibly exciting. It was an honor to share that perspective with the ABC7 audience." Dr. Lalezari's appearance on ABC7 Eyewitness News underscores his commitment to public health education and his role as a trusted medical voice in the Los Angeles community. In addition to his thriving surgical practice, Dr. Lalezari is a published researcher and former instructor at Johns Hopkins Medicine, where he completed his fellowship in bariatric and minimally invasive surgery. His unique academic background in neuroscience, combined with his extensive surgical training, positions him as a credible authority on the intersection of nutrition, supplementation, and overall health. As a physician who specializes in weight management and metabolic health, Dr. Lalezari frequently counsels patients on the role of nutrition and supplementation in achieving optimal health outcomes. His evidence-based approach to patient care and his dedication to staying at the forefront of medical research have earned him recognition as a Los Angeles Magazine "Top Doctor" from 2021 through 2024 and a SuperDoctors "Rising Star" designation from 2023 through 2025. More About Dr. Sepehr Lalezari Dr. Sepehr Lalezari is a double board-certified physician by the American Board of Surgery and the American Board of Obesity Medicine. A Fellow of the American College of Surgeons (FACS), Dr. Lalezari graduated magna cum laude and two years early from UCLA with a Bachelor of Science in Neuroscience before attending medical school at St. George's University School of Medicine. He completed surgical training at institutions throughout the United States, including Minnesota's prestigious Mayo Clinic, and went on to complete a highly specialized fellowship in bariatric and minimally invasive surgery at Johns Hopkins Medicine in Baltimore. At Johns Hopkins, he trained in cutting-edge procedures including robotic surgery, endoscopic surgery, and single-site surgical techniques. A former instructor at Johns Hopkins, Dr. Lalezari brings his commitment to education and innovation into his private practice at Lalezari Surgical, where he offers advanced bariatric, general, and minimally invasive surgical care to patients throughout the greater Los Angeles area. His practice is affiliated with Cedars-Sinai Medical Center, PIH Health Good Samaritan Hospital, and Dignity Health St. Mary's Hospital. Dr. Lalezari is also the founder of Bariatric Guru, an educational resource focused on nutritional support and supplementation for patients undergoing weight loss treatment. For more information about Dr. Sepehr Lalezari or to schedule a consultation, please visit . Media Contact Dr. Sepehr Lalezari Lalezari Surgical (213) 545-1656 SOURCE Lalezari Surgical 21% more press release views with Request a Demo

WEDNESDAY, Jan. 21, 2026 -- Use of acetaminophen as directed during pregnancy is not associated with an increased likelihood of autism spectrum disorder , attention-deficit/hyperactivity disorder (ADHD), or intellectual disability, according to a review published online Jan. 16 in The Lancet Obstetrics, Gynaecology, & Women's Health . Francesco D'Antonio, Ph.D., from the University of Chieti in Italy, and colleagues conducted a systematic review and meta-analysis to examine the associations between prenatal acetaminophen exposure and autism spectrum disorder, ADHD, or intellectual disability. The systematic review included 43 studies, and 17 were included in the meta-analysis. The researchers found that acetaminophen exposure during pregnancy was not associated with the risk for autism spectrum disorder, ADHD, or intellectual disability when considering sibling comparison studies. When considering only studies at low risk for bias according to the Quality In Prognosis Studies tool, no associations were seen between acetaminophen intake and autism spectrum disorder, ADHD, or intellectual disability. When considering all studies with adjusted estimates and those with more than five years of follow-up, this absence of association persisted. "Our findings suggest that previously reported links are likely to be explained by genetic predisposition or other maternal factors such as fever or underlying pain, rather than a direct effect of the paracetamol [acetaminophen] itself," lead author Asma Khalil, M.D., from St George's University Hospital NHS Foundation Trust in London, said in a statement. "The message is clear -- paracetamol remains a safe option during pregnancy when taken as guided." Abstract/Full Text